Sexual acquisition of HIV infection after solid organ transplantation: Late presentation and potentially fatal complications

Transpl Infect Dis. 2018 Aug;20(4):e12894. doi: 10.1111/tid.12894. Epub 2018 Apr 17.

Abstract

Introduction: While the growing knowledge on HIV among solid organ transplant recipients (SOT) is limited to either pretransplant infection or allograft transmission, there are only sparse reports describing HIV-infection after transplantation through sexual route, the primary mode of transmission in the general population.

Methods: From two different centers, we report nine new cases of HIV infection in SOT recipients attributed to sexual acquisition: eight cases of kidney-transplant recipients and one heart-transplant recipient.

Findings: There were nine cases of post-transplant HIV-infection detected among 14 526 transplants performed 1998 to 2015. In 6/9 cases, infection was contracted 5 years after SOT. All but one patient had stable allograft function under immunosuppressive therapy. The main trigger to diagnosis was late CMV disease and sexually transmitted diseases; five patients had CDC-stage 3 HIV infection. In 7/9 patients, virologic response and CD4 recovery were achieved within 3 months after starting antiretroviral therapy (ART). After an average of 3.6 years post diagnosis, 5/9 patients remained alive with well-controlled infection and functioning allograft.

Conclusion: Sexual acquisition of HIV infection after SOT represents a difficult challenge, as it may occur in any kind of transplant and at any time. The course of infection resembles that of the general population, with life-threatening infectious complications, but good response to ART. Assessment of lifestyle and risk behavior is paramount, as indications may be not disclosed without direct questioning.

Keywords: HIV infection; antiretroviral therapy; graft survival; heart transplantation; kidney transplantation; patient survival; sexually transmitted disease.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Female
  • Follow-Up Studies
  • Graft Rejection / prevention & control
  • HIV / drug effects
  • HIV / isolation & purification
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology*
  • HIV Infections / virology
  • Health Risk Behaviors
  • Heart Transplantation / adverse effects*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation / adverse effects*
  • Life Style
  • Male
  • Middle Aged
  • Postoperative Complications / drug therapy
  • Postoperative Complications / epidemiology*
  • Postoperative Complications / virology
  • Sustained Virologic Response

Substances

  • Antiviral Agents
  • Immunosuppressive Agents